Chemotherapy-induced peripheral neuropathy (CIPN) is one of the common side effects in tumor treatment and has now become a thorny problem limiting tumor treatment. Due to the complex mechanism of CIPN, it is commonly treated clinically with symptomatic treatment, supplemented by sedation and antidepressants, with poor therapeutic effects. In this paper, we review the treatment of CIPN with warm acupuncture in order to provide reference and basis for the clinical treatment of CIPN.

Liyao Chen, Yami Zhang. Overview of Warm Acupuncture for Chemotherapy-Induced Peripheral Neuropathy. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 8: 29-34. https://doi.org/10.25236/IJFM.2022.040805.

[1] Rao ZJ, Deng BQ. Advances in Chinese and Western medicine research on chemotherapy drug-induced peripheral neurotoxicity. World Science and Technology - Modernization of Chinese Medicine, 2020, 22(04):1307-1314.

[2] Staff N P, Grisold A, Grisold W, et al. Chemotherapy-induced peripheral neuropathy: A current review. Ann Neurol, 2017, 21(6): 1-10.

[3] Ma J, Kavelaars A, Dougherty P M, et al. Beyond symptomatic relief for chemotherapy- induced peripheral neuropathy: Targeting the source. Cancer, 2018, 124(11): 2289-2298.)

[4] Zis P, Paladini A, Piroli A, et al. Pain as a first manifestation of paraneoplastic neuropathies: a systematic review and meta- analysis. Pain Ther, 2017, 6(2): 143-151

[5] Brozou V, Vadalouca A, Zis P. Pain in platin-induced neuropathies: a systematic review and meta-analysis. Pain Ther, 2018, 7(1): 105-119.

[6] Avan R, Janbabaei G, Hendouei N, et al. The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial. J Res Med Sci, 2018, 23: 52.

[7] Cao W, Huo Jiege, Ding Rong. Treatment progress of chemotherapy-related peripheral neurotoxicity and strategies for prevention and treatment in Chinese medicine. World Science and Technology - Modernization of Chinese Medicine, 2019, 21(07):1458-1466.

[8] Duan HQ, Zhang LY. Research progress on antitumor drugs acting on microtubules. Advances in Modern Biomedicine, 2012, 12(33): 6578-6580. 

[9] Waseem M, Kaushik P, Tabassum H, et al. Role of mitochondrial mechanism in chemotherapy- induced peripheral neuropathy. Curr Drug Metab, 2018, 19(1): 47-54.

[10] McKeage MJ, Hsu T, Screnci D, et al. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer, 2015, 85 (8): 1219-1225.

[11] Jordan P, Carmo- fonseca M. Cisplatin inhibits synthesis of ribosomal RNA in vivo. Nucl Acids Res, 2014, 26(12): 2831-2836.

[12] Starobova H, Mueller A, Deuis J R, et al. Inflammatory and neuropathic gene expression signatures of chemotherapy- induced neuropathy induced by vincristine, cisplatin and oxaliplatin in C57BL/6J mice. J Pain, 2019: S1526-5900.

[13] Andersson BU, Tani E, Andersson U, et al. Tumor necrosis factor, interleukin 11 and leukemia inhibitory factor produced by Langerhans cells in Langerhans cell histiocytosis. J Pediatr Hematol Oncol, 2014, 26 (11): 706-711.

[14] Krishnan AV, Goldstein D, Friedlander M, et al. Oxaliplatin induced neurotoxicity and the deveopment of neuropathy. Muscle Nerve, 2005,32 (1): 51-60.

[15] Taylor AM, Ribeiro-da-Silva A. GDNF levels in the lower lip skin in a rat model of trigeminal neuropathic pain: implications for nonpeptidergic fiber reinnervation and parasympathetic sprouting. Pain, 2011, 152(7): 1502-1510.

[16] Bennett GJ, Liu GK, Xiao WH, et al. Terminal arbor degeneration-a novel lesion produced by the antineoplastic agent paclitaxel. Eur J Neurosci, 2011, 33(9): 1667-1676.

[17] Xiao WH, Zheng H, Zheng FY, et al. Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel- Evoked painful peripheral neuropathy in the rat. Neuroscience, 2011, 199: 461-469.

[18] Maj M A, Ma J, Krukowski K N, et al. Inhibition of mitochondrial p53 accumulation by PFT- mu prevents cisplatin- induced peripheral neuropathy. Front Mol Neurosci, 2017, 10(2017): 108.

[19] Zhu WC, Zhang ZW. Progress in the study of chemotherapy-induced peripheral neuropathy. International Journal of Anesthesiology and Resuscitation Journal, 2017, 38(5): 456-459.

[20] Wang X M, Lehky T J, Brell J M, et al. Discovering cytokines as targets for chemotherapy- induced painful peripheral neuropathy. Cytokine, 2012, 59(1): 3-9.

[21] Anand P, Elsafa E, Privitera R, et al. Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification. J Pain Res, 2019, 12(3): 2039-2052.

[22] Peters C M, Jimenez-Andrade J M, Kuskowski M A, et al. An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat. Brain Res, 2007, 1168: 46-59.

[23] Persson T, Popescu B O, Cedazo- Minguez A. Oxidative stress in Alzheimer’s disease: why did antioxidant therapy fail? Oxid Med Cell Longev, 2014, 2014: 427318.

[24] Dasari S, Tchounwou P B. Cisplatin in cancer therapy: Molecular mechanisms of action. Eur J Pharmacol, 2014, 740: 364-378.

[25] Ludman T, Melemedjian O K. Bortezomib and metformin opposingly regulate the expression of hypoxia- inducible factor alpha and the consequent development of chemotherapy- induced painful peripheral neuropathy. Mol Pain, 2019, 15(1): 1711-1724.

[26] Ganesh Yerra V, Negi G, Sharma S S, et al. Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF- κB pathways in diabetic neuropathy. Redox Biol, 2013, 1: 394-397.

[27] Jongen J L, Broijl A, Sonneveld P. Chemotherapy-induced peripheral neuropathies in hematological malignancies. J Neurooncol, 2015, 121: 229-237.

[28] Brami C, Bao T, Deng G. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review. Crit Rev Oncol Hematol, 2016, 98: 325-334.

[29] Grothey A, Nikcevich D A, Sloan J A, et al. Intravenous calcium and magnesium for oxaliplatin- induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol, 2011, 29(4): 421-427.

[30] Hershman D L, Lacchetti C, Dworkin R H, et al. Prevention and management of chemotherapy- induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol, 2014, 32(18): 1941-1967.

[31] Sun Zhangyan, Xiao Tianbao. Research progress of Huangqi Gui Zhi Wu Wu Wu Tang on the clinical and mechanism of peripheral neuropathy after chemotherapy. World abstract of latest medical information, 2017, 17(24):23-25+27.

[32] Wu T T, Jin Y, Lv J Q. Effects of Huangqi Guizhi Wuwu Tang combined with reverse acupuncture on peripheral neurotoxicity and immune function after chemotherapy in patients with malignant tumors. Shandong Medicine, 2015, 55(33):1-4.

[33] Zhu Yi, Huang Yan, Zhao Jimeng. From single to multiple: Progress in clinical application of warm acupuncture. World Journal of Integrative Chinese and Western Medicine, 2016, 11(03):440-444.

[34] Mu Yanyun, Niu Wenmin et al. Effects of electroacupuncture on striatal mitochondrial ATPase and overall antioxidant capacity in rats with focal cerebral ischemia-reperfusion. Shanghai Journal of Acupuncture and Moxibustion, 2007, 26(1): 42-44.

[35] Cui Deli, Fu Chengjie. Clinical observation of warm acupuncture in the treatment of oxaliplatin neurotoxicity. Gansu Traditional Chinese Medicine, 2011, 24(02):45-46. 

[36] Tian Yanping, Jia Yingjie. Efficacy of warm acupuncture on peripheral neurotoxicity after oxaliplatin chemotherapy. Tianjin Chinese medicine, 2011, 28(03):212-213.

[37] Cheng Xiaofang, Sun Yanyan et al. Literature-based analysis of key factors affecting clinical efficacy and safety of warm acupuncture and moxibustion. China Medicine Herald, 2017, 14(31):75-80.